Welcome to our dedicated page for Wearable Devices Ltd. SEC filings (Ticker: WLDS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Trying to pinpoint how much Wearable Devices Ltd. (WLDS) invests in neural-sensor R&D or when its engineers exercise options? This page brings every Wearable Devices Ltd. SEC filing explained simply, so you no longer dig through EDGAR on your own.
Use Stock Titan’s AI to navigate the filings that matter:
- 10-K annual report – our engine highlights patent counts, device-versus-licensing revenue, and capital needs for the next production run, giving you the Wearable Devices Ltd. annual report 10-K simplified.
- 10-Q quarterly earnings report – instant ratios and segment margins mean the Wearable Devices Ltd. quarterly earnings report 10-Q filing becomes a two-minute read.
- 8-K material events – whether it’s a new XR partnership or sensor breakthrough, find Wearable Devices Ltd. 8-K material events explained the moment they post.
- Form 4 insider trades – track Wearable Devices Ltd. insider trading Form 4 transactions and receive Wearable Devices Ltd. Form 4 insider transactions real-time alerts the second executives buy or sell.
- DEF 14A proxy statements – see how R&D talent is rewarded in the Wearable Devices Ltd. proxy statement executive compensation.
Every document is paired with concise, AI-powered summaries, accounting glossary links, and red-flag detection so you can focus on decisions, not page counts. Whether you’re monitoring Wearable Devices Ltd. earnings report filing analysis or executive stock transactions Form 4, our real-time feed ensures no filing is missed. Join analysts who already rely on Stock Titan for understanding Wearable Devices Ltd. SEC documents with AI and turn complex disclosures into actionable clarity.
Wearable Devices Ltd. prospectus supplement discloses financing and capitalization details and highlights material risks. The company reported an explanatory paragraph in its interim financial statements expressing substantial doubt about its ability to continue as a going concern. The document lists multiple classes of potentially dilutive securities, including options, warrants, pre-funded warrants, RSUs and reserved shares, with explicit counts such as 3,322,000 Ordinary Shares subject to shareholder approval for warrants, 564,059 RSUs outstanding, 98,589 IPO warrants, and additional warrants exercisable at $4.00 and $6.00 for 1,000,000 and 670,000 shares respectively. A pro forma capitalization table shows total shareholders' equity increasing to $20,104 on a pro forma basis after recent issuances described, and the assumed offering price used for illustrative pro forma calculations is $5.37 per share. The supplement also outlines permitted offering and distribution methods, material terms for warrants and units, and estimated offering expenses including $15,000 legal fees and $3,000 accounting fees.
Wearable Devices Ltd. filed a Form D for a new, non-public securities offering under Rule 506(b) seeking up to $4,020,000 in gross proceeds, with $0 sold to date and
Wearable Devices Ltd. filed a Form D to raise up to $4,000,000 under Regulation D, relying on Rule 506(b). The offering is for options/warrants and the securities issuable on exercise of those rights, with $0 sold to date and $4,000,000 remaining available. The company is incorporated in Israel and lists key executives including Asher Dahan (CEO & Chairman), CFO Tamar Fleisher, and other senior officers. The filing shows solicitation through A.G.P./Alliance Global Partners and reports $0 in sales commissions and finders fees and $0 of the offering proceeds proposed to be paid to named officers or directors. The minimum investment is listed as $0 and the issuer does not intend the offering to last more than one year.
Wearable Devices Ltd. (WLDS) prospectus supplement discloses capital structure changes, outstanding equity instruments, and a going-concern uncertainty. The company reports multiple classes of reserved and issuable Ordinary Shares (including options, warrants, RSUs and pre-funded warrants) totaling millions of potential shares that would dilute existing holders if issued. Pro forma adjustments reflect recent financings and a contemplated offering that raise net proceeds and increase pro forma net tangible book value per share from $1.67 to $1.91, and to $2.31 after this offering, with dilution per new investor estimated at $3.69 (61.48%). The filing lists specific reserved amounts (for example, 3,322,000 shares subject to shareholder approval and 564,059 RSUs) and describes distribution mechanics, underwriting limits, and legal/expense items.
FAQ
What is the current stock price of Wearable Devices Ltd. (WLDS)?
What is the market cap of Wearable Devices Ltd. (WLDS)?
